✦ LIBER ✦

Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage

✍ Scribed by Carey Kimmelstiel; Jehangir Badar; Lidija Covic; Sergio Waxman; Andrew Weintraub; Suzanne Jacques; Athan Kuliopulos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative pharmacodynamic evaluation o

✍ Jorge F Saucedo; Luis Garza; David C Wolford; Stephen L Cook; Kodangudi B Ramana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Assessing the Optimal Level of Platelet

✍ Steven R. Steinhubl 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 128 KB

Inhibition of Platelet Aggregation With

✍ Jorge F. Saucedo; Wady Aude; Rebecca Pacheco; Brett Thorn; Zakaria Matin; Khawaj 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

THE EFFICACY AND SAFETY OF TICAGRELOR AS

✍ Bansilal, Sameer; Wiviott, Stephen; Becker, Richard; Harrington, Robert; Himmelm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

DO WE STILL NEED A GLYCOPROTEIN IIB/IIIA

✍ Lili Dong; Yongshi Wang; Xianhong Shu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

A randomized, placebo-controlled trial t

✍ David A. Morrow; Chaim M. Brickman; Sabina A. Murphy; Kenneth Baran; Ricardo Kra 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 258 KB